AP/Washington Post Examines Challenges Parents, Physicians Face In Addressing HPV Vaccine
Main Category: Cancer / OncologyAlso Included In: Immune System / Vaccines; Cervical Cancer / HPV Vaccine; Pediatrics / Children's Health
Article Date: 30 Aug 2006 - 3:00 PDT
| Patient / Public: | ![]() |
4 (1 votes) |
| Healthcare Prof: | ![]() |
The AP/Washington Post on Sunday examined the challenges parents and physicians face in addressing the issues associated with Merck's human papillomavirus vaccine Gardasil (Irvine, AP/Washington Post, 8/27). FDA last month approved Gardasil for sale and marketing to girls and women ages nine to 26, and CDC's Advisory Committee on Immunization Practices later that month voted unanimously to recommend that all girls ages 11 and 12 receive the vaccine. ACIP also recommended that Gardasil be covered by the Vaccines for Children Program, which provides no-cost immunizations to children covered by Medicaid, Alaska-native and American Indian children, and some uninsured and underinsured children (Kaiser Daily Women's Health Policy Report, 8/21). According to the AP/Post, HPV is a "weighty topic" that has some parents, particularly those with adolescent girls, deciding whether they should tell their daughters that Gardasil is a vaccine against cancer or if they should explain that HPV is a sexually transmitted infection that can cause cervical cancer and genital warts. According to a CDC survey, about 7% of children under age 13 have had sex and about 25% have done so by age 15. The agency also estimates that more than six million U.S. residents -- the majority of them youth -- acquire HPV annually. Theresa Rohr-Kirchgraber, an adolescent and internal medicine specialist at the Emory University School of Medicine in Atlanta, said parents should recognize the seriousness of such statistics when discussing the HPV vaccine with their daughters. Susan Rosenthal, a pediatric psychologist at the University of Texas Medical Branch in Galveston, said several surveys have found that parents' most frequent concerns are with the seriousness of the illness and whether the vaccine will be an effective prevention method, "They're much less concerned how the infection is transmitted" (AP/Washington Post, 8/27).
"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our cancer / oncology section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/50661.php>
APA
http://www.medicalnewstoday.com/releases/50661.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





